D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$625M |
| 3 |
Merck
MRK
|
+$498M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Fortinet
FTNT
|
+$321M |
Top Sells
| 1 |
Tesla
TSLA
|
+$696M |
| 2 |
Adobe
ADBE
|
+$610M |
| 3 |
Accenture
ACN
|
+$518M |
| 4 |
Microsoft
MSFT
|
+$495M |
| 5 |
Broadcom
AVGO
|
+$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Cross Country Healthcare
CCRN
$411M
| $5.22M | ﹤0.01% |
388,433
+198,172
| +104% | +$2.66M |
|
1152
Enanta Pharmaceuticals
ENTA
$177M
| $5.19M | ﹤0.01% |
501,372
-32,809
| -6% | -$340K |
|
1153
Hyatt Hotels
H
$13.7B
| $5.17M | ﹤0.01% |
33,981
+25,824
| +317% | +$3.93M |
|
1154
Fortis
FTS
$24.9B
| $5.15M | ﹤0.01% |
113,426
-46,941
| -29% | -$2.13M |
|
1155
iShares Russell 2000 Growth ETF
IWO
$12.6B
| $5.15M | ﹤0.01% |
18,142
-27,812
| -61% | -$7.9M |
|
|
NTST
1156
NETSTREIT Corp
NTST
$1.75B
| $5.13M | ﹤0.01% |
310,639
+73,297
| +31% | +$1.21M |
|
1157
NCR Voyix
VYX
$1.77B
| $5.13M | ﹤0.01% |
377,768
-482,884
| -56% | -$6.55M |
|
1158
Green Plains
GPRE
$631M
| $5.11M | ﹤0.01% |
377,127
+90,405
| +32% | +$1.22M |
|
1159
Cognyte Software
CGNT
$622M
| $5.11M | ﹤0.01% |
752,017
-109,135
| -13% | -$741K |
|
1160
US Physical Therapy
USPH
$1.22B
| $5.09M | ﹤0.01% |
60,156
+32,197
| +115% | +$2.72M |
|
1161
Capital One
COF
$143B
| $5.09M | ﹤0.01% |
33,987
-412,841
| -92% | -$61.8M |
|
1162
CONMED
CNMD
$1.64B
| $5.08M | ﹤0.01% |
70,628
+45,108
| +177% | +$3.24M |
|
|
SGI
1163
Somnigroup International Inc.
SGI
$17.6B
| $5.08M | ﹤0.01% |
92,987
-159,648
| -63% | -$8.72M |
|
1164
RxSight
RXST
$381M
| $5.06M | ﹤0.01% |
102,391
-172,447
| -63% | -$8.52M |
|
1165
Blackstone
BX
$142B
| $5.06M | ﹤0.01% |
33,044
-141,887
| -81% | -$21.7M |
|
1166
BOK Financial
BOKF
$7.06B
| $5.06M | ﹤0.01% |
48,326
-18,218
| -27% | -$1.91M |
|
1167
Lattice Semiconductor
LSCC
$8.82B
| $5.03M | ﹤0.01% |
94,835
+19,455
| +26% | +$1.03M |
|
1168
MGP Ingredients
MGPI
$596M
| $5.03M | ﹤0.01% |
60,428
-9,078
| -13% | -$756K |
|
1169
Energizer
ENR
$2.02B
| $5.03M | ﹤0.01% |
158,351
+104,976
| +197% | +$3.33M |
|
1170
GSK
GSK
$82.2B
| $5.02M | ﹤0.01% |
+122,856
| New | +$5.02M |
|
1171
McEwen Inc.
MUX
$748M
| $5.02M | ﹤0.01% |
539,965
+120,590
| +29% | +$1.12M |
|
1172
Robert Half
RHI
$3.61B
| $5.02M | ﹤0.01% |
74,425
-140,241
| -65% | -$9.45M |
|
|
MBAV
1173
M3-Brigade Acquisition V Corp. Class A Ordinary shares
MBAV
$379M
| $5.01M | ﹤0.01% |
+500,000
| New | +$5.01M |
|
1174
Otter Tail
OTTR
$3.48B
| $4.99M | ﹤0.01% |
63,889
+30,332
| +90% | +$2.37M |
|
1175
Plains GP Holdings
PAGP
$3.7B
| $4.98M | ﹤0.01% |
269,403
-48,719
| -15% | -$901K |
|